IL249686A0 - Biological characterization of a product related to glatiramer cetate using mammalian and human cells - Google Patents

Biological characterization of a product related to glatiramer cetate using mammalian and human cells

Info

Publication number
IL249686A0
IL249686A0 IL249686A IL24968616A IL249686A0 IL 249686 A0 IL249686 A0 IL 249686A0 IL 249686 A IL249686 A IL 249686A IL 24968616 A IL24968616 A IL 24968616A IL 249686 A0 IL249686 A0 IL 249686A0
Authority
IL
Israel
Prior art keywords
mammalian
human cells
drug product
glatiramer acetate
related drug
Prior art date
Application number
IL249686A
Other languages
English (en)
Hebrew (he)
Inventor
Michael Hayden
Liat Hayardeny
Iris Grossman
David Ladkani
Fadi George Towfic
Sarah Elisabeth Kolitz
Benjamin James Zeskind
Tal Hasson
Original Assignee
Teva Pharma
Michael Hayden
Liat Hayardeny
Iris Grossman
David Ladkani
Fadi George Towfic
Sarah Elisabeth Kolitz
Benjamin James Zeskind
Tal Hasson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharma, Michael Hayden, Liat Hayardeny, Iris Grossman, David Ladkani, Fadi George Towfic, Sarah Elisabeth Kolitz, Benjamin James Zeskind, Tal Hasson filed Critical Teva Pharma
Publication of IL249686A0 publication Critical patent/IL249686A0/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5023—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on expression patterns
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
IL249686A 2014-07-01 2016-12-21 Biological characterization of a product related to glatiramer cetate using mammalian and human cells IL249686A0 (en)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US201462019857P 2014-07-01 2014-07-01
US201462020358P 2014-07-02 2014-07-02
US201462025953P 2014-07-17 2014-07-17
US201462047437P 2014-09-08 2014-09-08
US201462078369P 2014-11-11 2014-11-11
US201562134245P 2015-03-17 2015-03-17
US201562162308P 2015-05-15 2015-05-15
PCT/US2015/038901 WO2016004250A2 (en) 2014-07-01 2015-07-01 Biological characterization of a glatiramer acetate related drug product using mammalian and human cells

Publications (1)

Publication Number Publication Date
IL249686A0 true IL249686A0 (en) 2017-02-28

Family

ID=55020098

Family Applications (1)

Application Number Title Priority Date Filing Date
IL249686A IL249686A0 (en) 2014-07-01 2016-12-21 Biological characterization of a product related to glatiramer cetate using mammalian and human cells

Country Status (6)

Country Link
EP (1) EP3164710A4 (es)
CA (1) CA2952849A1 (es)
IL (1) IL249686A0 (es)
TW (1) TW201610169A (es)
UY (1) UY36197A (es)
WO (1) WO2016004250A2 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018053109A1 (en) * 2016-09-14 2018-03-22 Teva Pharmaceutical Industries Ltd. Gene expression characterization of a glatiramer acetate related drug product in mammalian and human cells
CN116637123B (zh) * 2023-06-07 2024-02-13 上海市东方医院（同济大学附属东方医院） 敲降或下调C15orf39基因表达的试剂在制备治疗胃癌的药物中的应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2690402A1 (en) * 2007-06-21 2008-12-24 Momenta Pharmaceuticals, Inc. Copolymer assay

Also Published As

Publication number Publication date
CA2952849A1 (en) 2016-01-07
WO2016004250A2 (en) 2016-01-07
EP3164710A4 (en) 2018-04-11
TW201610169A (zh) 2016-03-16
WO2016004250A3 (en) 2016-03-17
EP3164710A2 (en) 2017-05-10
UY36197A (es) 2016-01-29

Similar Documents

Publication Publication Date Title
IL279001A (en) Nasal medicines and methods of using them
IL249189A0 (en) Combined treatment of antibodies against human cd40 and antibodies against human pd-l1
EP3204113A4 (en) Methods and apparatus for stimulation of biological tissue
EP3039624A4 (en) Merchandise activity sensor system and methods of using same
EP3149025A4 (en) Cell penetrating peptides and methods of making and using thereof
SG11201700292WA (en) Biological tissue adhesive composition and method of preparation thereof
SG11201701444RA (en) Methods for the production and use of mycelial liquid tissue culture
EP3167046A4 (en) Manufacture and cryopreservation of fucosylated cells for therapeutic use
EP3202305A4 (en) Disposable endoscope and system
EP3186365A4 (en) Identification of cancer genes by in-vivo fusion of human cancer cells and animal cells
EP3183026A4 (en) Implants for localized drug delivery and methods of use thereof
EP3234107A4 (en) B cells for in vivo delivery of therapeutic agents
HK1247232A1 (zh) 細胞和組織培養容器
EP3209251A4 (en) Platinum-catalyzed silicone drug delivery devices and methods of use thereof
EP3291835A4 (en) NKT CELL SUBASSEMBLY FOR PERSISTENCE AND THERAPEUTIC ACTIVITYIN VIVO
ZA201703833B (en) Oral care products and methods of use and manufacture thereof
EP3123176A4 (en) Diagnosis of multiple sclerosis in human and animal subjects
EP3310365C0 (en) EXTRACELLULAR VESICLES FROM OSTEOBLASTIC LINEAGE CELLS, FOR THERAPEUTIC AND DIAGNOSTIC USE
EP3186354A4 (en) Modular single-use kits and methods for preparation of biological material
EP3236992A4 (en) Peptides and their use in the treatment of skin
FR3021318B1 (fr) Produits derives de la 20-hydroxyecdysone et leur utilisation dans la preparation de medicaments
PL3132020T3 (pl) Naczynie do hodowli komórek i jego zastosowanie
EP3491117A4 (en) SIMULTANEOUS SEPARATION AND ACTIVATION OF T CELLS FROM BLOOD PRODUCTS WITH FOLLOWING STIMULATION FOR THE EXPANSION OF T CELLS
EP3111969A4 (en) Medical material and medical instrument using medical material
GB201500500D0 (en) Biological materials and therapeutic uses thereof